STOCK TITAN

LifeStance Health (LFST) reshapes board with three new directors and RSU grants

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

LifeStance Health Group, Inc. reported changes to its board of directors. Jeffrey Rhodes resigned from the board and all committees effective immediately, and the company stated his resignation was not due to any disagreement with the company.

To fill board vacancies, the board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as directors. Mr. Justice and Ms. Goltermann were named Class II directors, serving until the 2029 annual meeting of stockholders, while Mr. Shabab was named a Class III director, serving until the 2027 meeting.

Mr. Justice joined the audit committee and the quality and compliance committee, Ms. Goltermann joined the compensation and nominating and governance committees, and Mr. Shabab joined the nomination and governance committee. Under the 2021 Equity Incentive Plan, Mr. Justice and Ms. Goltermann each received 35,492 restricted stock units, which vest under a time- and performance-based agreement, subject to their continued board service.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
RSUs to Thurman Justice 35,492 restricted stock units Initial award under 2021 Equity Incentive Plan, time- and performance-based vesting
RSUs to Lori Goltermann 35,492 restricted stock units Initial award under 2021 Equity Incentive Plan, time- and performance-based vesting
Class II director term end 2029 annual meeting of stockholders Terms for Thurman Justice and Lori Goltermann
Class III director term end 2027 meeting of stockholders Term for Safwan Shabab
Stockholder’s Agreement date June 9, 2021 Agreement governing Safwan Shabab’s board appointment
restricted stock units financial
"each received an initial award of 35,492 restricted stock units that will vest"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Equity Incentive Plan financial
"In connection with their appointments, pursuant to the Company’s 2021 Equity Incentive Plan"
audit committee financial
"Mr. Justice will serve as a member of the audit committee and the quality and compliance committee"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
compensation committee financial
"Ms. Goltermann will serve as a member of the compensation committee and nominating and governance committee"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Stockholder’s Agreement regulatory
"Mr. Shabab was appointed to the Board in accordance with and pursuant to a Stockholder’s Agreement"
emerging growth company regulatory
"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ... Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What board change did LifeStance Health (LFST) announce on July 2, 2026?

LifeStance Health announced that director Jeffrey Rhodes resigned from the board and all its committees, effective immediately. The company stated his resignation was not due to any disagreement with LifeStance Health or its operations, providing reassurance about the nature of the departure.

Who joined the LifeStance Health (LFST) board and how long will they serve?

The board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as directors. Justice and Goltermann became Class II directors serving until the 2029 annual meeting, while Shabab became a Class III director serving until the 2027 meeting of stockholders under the company’s classified board structure.

Which board committees will the new LifeStance Health (LFST) directors serve on?

Thurman Justice will serve on the audit committee and the quality and compliance committee. Lori Goltermann will serve on the compensation committee and the nominating and governance committee. Safwan Shabab will serve on the nomination and governance committee, helping oversee governance matters for the board.

What equity awards did new LifeStance Health (LFST) directors receive?

Under the 2021 Equity Incentive Plan, Thurman Justice and Lori Goltermann each received an initial award of 35,492 restricted stock units. These RSUs vest according to a time- and performance-based restricted stock unit agreement, contingent on each director’s continued service on the LifeStance board.

How was Safwan Shabab’s appointment to the LifeStance Health (LFST) board governed?

Safwan Shabab’s appointment was made in accordance with a Stockholder’s Agreement dated June 9, 2021 between LifeStance Health and certain stockholders. That agreement, previously filed as an exhibit with the SEC, provides specific rights related to board representation for those stockholders.
false 0001845257 0001845257 2026-07-02 2026-07-02
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 2, 2026

 

 

LifeStance Health Group, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-40478   86-1832801

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

4800 N. Scottsdale Road  
Suite 2500  
Scottsdale, Arizona   85251
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: 425 279-8500

 

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.01 per share   LFST   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 2, 2026, Jeffrey Rhodes notified the LifeStance Health Group, Inc. (the “Company”) board of directors (the “Board”) of his resignation from the Board and all of its committees, effective immediately. The resignation is not a result of any disagreement between Mr. Rhodes and the Company.

In connection with Mr. Rhodes’ resignation and to fill vacancies on the Board, on July 2, 2026, the Board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as a directors of the Company. Mr. Justice and Ms. Goltermann were appointed as Class II directors and will initially serve until the Company’s 2029 annual meeting of stockholders and Mr. Shabab was appointed as a Class III director and will initially serve until the Company’s 2027 meeting of stockholders. Mr. Justice will serve as a member of the audit committee and the quality and compliance committee of the Board, Ms. Goltermann will serve as a member of the compensation committee and nominating and governance committee of the Board and Mr. Shabab will serve as a member of the nomination and governance committee of the Board.

In connection with their appointments, pursuant to the Company’s 2021 Equity Incentive Plan, Mr. Justice and Ms. Goltermann each received an initial award of 35,492 restricted stock units that will vest according to the terms of a time-and performance-based restricted stock unit agreement, subject to Mr. Justice and Ms. Goltermann’s continued service on the Board.

Mr. Shabab was appointed to the Board in accordance with and pursuant to a Stockholder’s Agreement, dated as of June 9, 2021, by and between the Company and certain of its stockholders, which is filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 15, 2021.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    LIFESTANCE HEALTH GROUP, INC.
Date: July 7, 2026     By:  

/s/ Ryan Pardo

    Name:   Ryan Pardo
    Title:   Chief Legal Officer and Secretary

Filing Exhibits & Attachments

3 documents